Noninvasive Evaluation of HER2 Expression and Heterogeneity in Urothelial Carcinoma on 68Ga-HER2-affibody PET/CT
68Ga-HER2 affibody PET/CT is a feasible method to detect the HER2 status and heterogeneity in UC patients noninvasively. This method provides a valuable tool for identifying patients who benefit from HER2-target therapy.
Authors
- HONGYUN LI
- Xiaoying Li (ORCID: https://orcid.org/0000-0001-6541-064X)
- Zihao Tao (ORCID: https://orcid.org/0000-0003-1898-8160)
- Xiaojiang Duan (ORCID: https://orcid.org/0000-0002-3989-297X)
- Xueqi Chen (ORCID: https://orcid.org/0000-0002-6648-4584)
- Q. Tang
- Lei Yin
- Xuesong Li
- Jianhua Zhang
Institutions
- Peking University (CN)
- Peking University First Hospital (CN)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-12-08
- DOI
- https://doi.org/10.1097/rlu.0000000000006239
- Citations
- 1
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.01